European Union - English - EMA (European Medicines Agency)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immune sera and immunoglobulins, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5.1).obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.1).

United States - English - NLM (National Library of Medicine)

sandoz inc. - desflurane (unii: crs35bz94q) (desflurane - unii:crs35bz94q) - desflurane 240 ml in 240 ml - desflurane, usp, liquid for inhalation is indicated as an inhalation agent for induction of anesthesia for inpatient and outpatient surgery in adults. desflurane, usp, liquid for inhalation is contraindicated as an inhalation agent for the induction of anesthesia in pediatric patients because of a high incidence of moderate to severe upper airway adverse events. desflurane, usp, liquid for inhalation is indicated as an inhalation agent for maintenance of anesthesia for inpatient and outpatient surgery in adults and in pediatric patients. after induction of anesthesia with agents other than desflurane, usp, liquid for inhalation, and tracheal intubation, desflurane, usp, liquid for inhalation is indicated for maintenance of anesthesia in infants and children. desflurane, usp, liquid for inhalation is not approved for maintenance of anesthesia in non-intubated children due to an increased incidence of respiratory adverse reactions, including coughing, laryngospasm, and secretions [see warnings and preca

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

piramal critical care b.v. - desflurane 100 % - inhalation vapour, liquid - 100 % - desflurane - desflurane

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - desflurane, quantity: 1 ml/ml - inhalation - excipient ingredients: - desflurane sandoz is indicated as an inhalation agent for maintenance of anaesthesia. desflurane sandoz is not recommended for mask induction of anaesthesia because of a high incidence of moderate to severe upper airway adverse events.

Canada - English - Health Canada

blue-zone technologies ltd - desflurane - liquid - 100% - desflurane 100% - inhalation anesthetics

United States - English - NLM (National Library of Medicine)

piramal critical care inc - desflurane (unii: crs35bz94q) (desflurane - unii:crs35bz94q) - desflurane, usp, liquid for inhalation is indicated as an inhalational agent for induction of anesthesia for inpatient and outpatient surgery in adults. desflurane, usp, liquid for inhalation is contraindicated as an inhalational agent for the induction of anesthesia in pediatric patients because of a high incidence of moderate to severe upper airway adverse events. desflurane, usp, liquid for inhalation is indicated as an inhalation agent for maintenance of anesthesia for inpatient and outpatient surgery in adults and in pediatric patients. after induction of anesthesia with agents other than desflurane, usp, liquid for inhalation and tracheal intubation, desflurane, usp, liquid for inhalation is indicated for maintenance of anesthesia in infants and children. desflurane, usp, liquid for inhalation is not approved for maintenance of anesthesia in non-intubated children due to an increased incidence of respiratory adverse reactions, including coughing, laryngospasm, and secretions [ see warnings and precaut

United Kingdom - English - myHealthbox

piramal healthcare uk limited - desflurane - inhalation vapour liquid - 100% (v/v) - nervous system; anesthetics; general; halogenated hydrocarbons - it is indicated as an inhalation agent for induction and maintenance of general anesthesia for inpatient and outpatient surgery in adults and for the maintenance of anaesthesia in infants and children.

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - desflurane (unii: crs35bz94q) (desflurane - unii:crs35bz94q) - desflurane 240 ml in 240 ml - 1.1 induction of anesthesia suprane is indicated as an inhalation agent for induction of anesthesia for inpatient and outpatient surgery in adults. suprane is contraindicated as an inhalation agent for the induction of anesthesia in pediatric patients because of a high incidence of moderate to severe upper airway adverse events. 1.2 maintenance of anesthesia suprane is indicated as an inhalation agent for maintenance of anesthesia for inpatient and outpatient surgery in adults and in pediatric patients. after induction of anesthesia with agents other than suprane, and tracheal intubation, suprane is indicated for maintenance of anesthesia in infants and children. suprane is not approved for maintenance of anesthesia in non-intubated children due to an increased incidence of respiratory adverse reactions, including coughing, laryngospasm, and secretions [see warnings and precautions (5.3) and clinical studies (14.5)]. suprane (desflurane, usp) is indicated as an inhalation agent for induction of anesthesia f

Malta - English - Medicines Authority

baxter healthcare limited - desflurane - inhalation vapour, liquid - desflurane 100 percent - anesthetics

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tagros chemicals india private limited - transfluthrin - unknown - transfluthrin pyrethroid active 0.0 - active constituent